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Traditional herbal medicines such as Morinda morindoïdes are used for treatment of intestinal disorders 
including constipation in Ivory Coast. The aim of present study was to investigate the effect of total protein of 
Morinda morindoïdes extract (PT-Mm) on rabbit duodenum contractility and the involved possible 
mechanism(s). PT-Mm was extracted according to the saturation method of Dawson with ammonium sulfate. 
The cholinergic effect of the extract was determined by the in vitro organ bath method. The 
acetylcholinesterase (AChE) extracted from rabbit duodenum and it activity was determined by Ellman’s as ay 
using acetylthiocholine (ASCh) as substrate. PT-Mm concentrations (40, 80, 120 and 200 µg/mL) showed 
dose-dependent effect a both tonicity and amplitude of the duodenum spontaneous contractions. The effective 
concentration which induces 50% effect of PT-Mm (EC50) was obtained with 68.57 ± 0.89 µg/mL. The 
antagonist tests carried out showed a considerable eduction (90%) in the amplitudes of duodenal contractions 
in the presence of atropine, but with nifedipine, the contractions were completely inhibited. PT-Mm also 
exerted non-competitive inhibition on AChE (Vmax = 5687 mM/min and KM = 578 µM). These results suggest 
that PT-Mm could stimulate duodenum smooth muscle contraction because it contains anti-AChE and 
cholinomimetic substances which, through muscarinic eceptors, increase Ca2+ mobilization from extracellular. 
Therefore, PT-Mm could be used as a laxative, due to its stimulating effects on duodenal contractility. 
© 2012 International Formulae Group. All rights reserved. 
 




Many people nowadays turn to the use 
of natural products for treatment of gastro-
intestinal disorders including diarrhoea, 
indigestion and constipation (Ragone et al., 
2007). Constipation is a highly prevalent often 
chronic gastro-intestinal disorder that affects 
adults (Bosshard et al., 2004; Muller-Lissner, 
2009). Natural products have served as a 
source of medicine for centuries and about 
half of the pharmaceuticals in use today are 
derived from natural products (Ginsburg and 
Deharo, 2011). Dependance on plants as the 
source of medicines is prevalent in developing 




countries where traditional medicine plays a 
major role in health care (Azam et al., 2011).  
Morinda morindoïdes (baker) Miln-
Redh (Rubiaceae) is well known in the 
traditional medicine practice of tropical 
countries. In the Democratic Republic of 
Congo, M. morindoïdes has long been used in 
villages and towns in the treatment of some 
parasitic diseases, and the leaf extracts of the 
plant have been shown to possess 
antiprotozoal activity particularly against 
Entamoeba histolytica and rheumatic pains 
(Cimanga et al., 2003; Cimanga et al., 2006). 
In Ivory Coast, Morinda morindoïdes is used 
as an antifungal agent and to treat diarrhoea 
(Meite et al., 2009). Recently Zirihi et al. 
(2005) showed the activity of the ethanol 
extract of M. morindoïdes against 
chloroquine-resistant FcB1/Colombia strain of 
Plasmodium falciparum. Also, ten flavonoids 
and eight iridoid glycosides have been 
isolated from the butanol and ethyl acetate 
fractions by Cimanga et al. (1999). Some 
interesting biological activities related to some 
of its traditional uses, including antioxidative 
(Cimanga et al., 1999), cardioinhibitory 
(N’Guessan et al., 2002), anticomplementary 
(Cimanga et al., 2003), antiamoebic (Cimanga 
et al., 2006), immunologic (Mankele et al., 
2006), antimalarial (Cimanga et al., 2008) and 
spasmolytic (Cimanga et al., 2010) activities 
were previously reported. The present work 
was planned to examine in vitro the laxative 
activity of total protein extract of Morinda 
morindoides and its mechanism on duodenal 
smooth muscle contractility. 
 
MATERIALS AND METHODS 
Plant materiel 
The leaves of Morinda morindoïdes 
(Rubiaceae) were collected from Daloa 
(central west region of Ivory Coast) in June 
2009. The plant was identified and 
authenticated by Pr Ake Assi of the 
Department of Botany, University of Cocody. 
A voucher specimen (no 17710) of the plant 
was deposited in the herbarium of the 




Rabbits of both sexes, 12-16 weeks old, 
weighing 1.5-2 kg and bred at the Department 
of Biosciences, (University of Cocody-
Abidjan), were used for the experiments. All 
animals were kept at constant humidity (60%) 
and temperature (25 °C) in a 12- hour light / 
dark cycle. They had free access to food and 
water. 
The animals were cared for and treated 
according to the principles for using of 
laboratory animals, and approval for the 
studies was given by the ethical committee of 
the University of Cocody- Abidjan. The 
equipment, handling and sacrificing of the 
animals were in accordance with the European 
Council legislation 87/609/EEC for the 
protection of experimental animals (Mitjans et 
al., 2008). Before the experiment rabbits were 
deprived from food for 24 h but had free 
access to water. 
 
Drugs and chemicals 
The drugs used were: atropine, 
nifedipine, DTNB, acetylthiocholine and 
ammonium sulfate. All chemicals were 
purchased from Sigma Chemicals Co. (St 
Louis, MQ, USA), Aldrich Chemical Co. 
(Steineheim, Germany), and Merck 
(Darmstadt, Germany). 
 
Preparation of PT-Mm 
M. morindoïdes leaves were cleaned of 
extraneous matter, air-dried at room 
temperature for 7 days and ground into a fine 
powder. The powder was mixed with distilled 
water (80 g of powder in 2 L of distilled 
water) for 24 h with constant stirring .The 




extract was filtered twice through cotton wool, 
then through Whatman filter paper (No.1). 
The filtrate is saturated with 
ammonium sulfate to 90% saturation 
according to the method of Dawson et al. 
(1986) for the precipitation of protein. After 
homogenization, the solution was kept for 24 
hours and subsequently centrifuged 4000 
trs/min. A fraction that was obtained showed 
two phases: an upper phase (supernatant) and 
a lower phase (the sediment) which was our 
protein extract. The sediment collected was 
dialyzed against distilled water (Wilson and 
Walker, 1994), with a synthetic membrane of 
dialysis. The presence of protein in the 
dialyzed pellet was revealed by the Lowry test 
(Lowry et al., 1951). Protein solution was 
freeze-dried for better storage stability 
(Osterlund and Janson, 1997) and the resulting 
powder was our total proteins extract of 
Morinda morindoides leaves (PT-Mm). 
 
Duodenum tissue preparation  
On the day of experiment, rabbits were 
sacrificed by a sharp blow on the neck. After a 
median laparotomy, duodenal muscle strips (2 
cm) were dissected and mounted in an organ 
bath containing Tyrode solution (100 mL) 
between two stainless steel hooks vertically. 
The lower hook was fixed at the bottom of the 
organ bath and the upper one was connected 
to an isotonic transducer (Harvard transducer, 
UK) connected to a recorder (Harvard 
Universal Oscillograph, UK). The Tyrode 
solution composition (pH 7.4 and 37 °C) was 
(in mM): NaCl (130.5); KCl (5.63); CaCl2 
(2.16); MgCl2 (0.24); NaH2PO4 (1.18); 
NaHCO3 (11.90) and glucose (11.10) which 
was continuously bubbled with air (Madeira et 
al., 2002). The initial tension was 1 g 
throughout the experiment and equilibrium 
period was 30 min. After equilibrium period 
spontaneous contractions were recorded for 5 
min in the absence (control) or presence of 
increasing doses (40 µg/mL to 200 µg/mL) of 
PT-Mm. Each test was repeated three times 
and duodenum strip was washed 2-3 times 
with the Tyrode solution in order to avoid the 
cumulative effects of products. Antagonist 
tests with atropine and nifedipine were made 
at the concentration for which these 
substances have no effect on the contractile 
activity of rabbit duodenum. Thus, different 
doses of antagonist were assessed on 
contractile activity of duodenal smooth 
muscle in the presence of PT-Mm. 
  
In vitro  analysis of AChE activity 
Enzyme extraction was performed 
according to the method of Khoa and Ochillo 
(1987). A length of duodenum weighing 1g 
was added to 50 mL phosphate buffer and 
crushed with a mortar (Ultra Turax T 25). The 
homogenate was centrifugated and the 
supernatant was used for the assays. The 
AChE activity was determined in vitro by 
Ellman et al. (1961) method. The assay 
contained a mixture of 100 µL of 5,5’- dithio-
bis-(2-nitro) benzoic acid (DTNB) (0.01 M) 
and 25 µL of acetylthiocholine (ASCh) of 
varying concentrations in 50 mM potassium 
phosphate buffer, pH 7.8, followed by the 
addition of 75 µL AChE in 50 mM potassium 
phosphate buffer, pH 7.8. The enzymatic 
reaction was initiated at 25 °C and the 
absorbance change was monitored at 412 nm 
with a spectrophotometer (Amresa, Barcelona, 
Spain). 
 
Enzyme kinetic analysis 
To study the effect of PT-Mm extract 
on AChE activity, the kinetic analysis of the 
duodenum AChE solution in the presence of 
the extract was performed. The mixture of 
enzyme and PT-Mm (1.5 mg/mL) was 
preincubated at 37 °C for 5 min, and then the 
substrate in varying concentrations was added 
and immediately stirred for 10 s. The change 




of absorbance at 412 nm was monitored and 
the initial velocity (dA/min) of the reaction 
was calculated from the absorbance change. 
The kinetics of AChE in the presence of PT-
Mm was determined by the Lineweaver and 
Burk (1934) (LB) plot. The LB plot represents 
the reciprocal velocities substrate 
concentrations of the control (without 
inhibitor) and the series of inhibitor 
concentrations (Trevor, 1981). 
 Statistical analysis 
Data were analyzed by one-way 
ANOVA followed by Dennet’s t-test using 
instat (Graph Pad software, USA). A p value 




Dose-response effect of PT-Mm on rabbit 
duodenum 
Figure 1 shows the recordings of the 
mechanical activity of the rabbit duodenum in 
the presence of PT-Mm. In this study, the 
different doses of the extract (40, 80, 160 and 
200 µg/mL) showed dose dependent increase 
on duodenal contractions. The recording 
obtained at 40 µg/mL showed a no significant 
(p > 0.05) increase in the amplitude of the 
spontaneous contractions (Figure 1A). At 80 
µg/mL of PT-Mm, the increase in the 
amplitude of duodenal contractions was 
significant (p < 0.05) (Figure 1B), but it was 
very significant (p < 0.01) at the dose of 120 
µg/mL of the extract (Figure 1C); while at 200 
µg/mL of PT-Mm the amplitude of 
contractions reached the maximum (100 %) (P 
< 0.01) (Figure 1D). 
The results presented on Figure 2 
showed the dose-response curve of duodenum 
contractions induced by increasing doses of 
PT-Mm. The EC50 was determined from the 
curve of the amplitude to be 68.57 ± 4.89 
µg/ml. 
 
Characterization of the active compounds 
of PT-Mm  
Antagonism effect of atropine and PT-Mm 
on duodenal contractility. 
Figure 3 shows the interaction between 
PT-Mm and increasing concentrations of 
atropine (muscarinic receptor blocker). The 
gradual increase in the amplitude of 
contractions recorded with PT-Mm extract 
was inhibited significantly (81.25% 
inhibition) by atropine (4.10-6 mg/mL). 
Antagonism effect of nifedipine and PT-Mm 
on duodenal contractility  
Figure 4 expresses the interaction 
between PT-Mm and the varying 
concentrations of nifedipine (calcium 
channels blocker). The contractile effect of 
PT-Mm on spontaneous contractions of 
duodenal smooth muscle was completely 
inhibited by nifedipine at 1 µg/mL. 
Effect of PT-Mm on hydrolytic action of 
AChE 
The kinetic analysis of AChE inhibition 
by PT-Mm (40 µg/mL) was shown in Figure 
5. PT-Mm inhibited AChE in non-competitive 
manner. The chart of Lineweaver and Burk 
(1934) in which the lines obtained cross the 
Y-axis and the X-coordinates in two distinct 
points which correspond respectively to 
1/Vmax and -1/KM led to the determination of 
Vmax and KM. The KM and Vmax values for 
AChE in the absence of PT-Mm were 578 µM 
and 6664 mM/min, respectively. In the 
presence of PT-Mm the corresponding values 
were: KM = 578 µM and Vmax = 5687 
mM/min.
 




















































Figure 2: Dose-response curve of graded concentrations of PT-Mm extract on 
rabbit isolated duodenum. Values are expressed as me n ± S.E.M (n = 3). * P < 
























Figure 3: Antagonistic effect of Atropine and PT-Mm extract on the duodenal 
contractions. Values are expressed as mean ± S.E.M (n = 3) * P < 0.05; **P < 0.01 
compared to control. 
































































Figure 4: Antagonistic effect of Nifedipine and PT-Mm on the duodenal 
contractions. Values are expressed as mean ± S.E.M (n = 3). * P < 0.05; **P < 0.01 
compared to control. 
 
 














Figure 5: Linewaver-Burk (LB) plot of initial enzyme velocity (V) against the 









The leaves Morinda morindoïdes are 
usually used in folk medicine for the treatment 
of gastro-intestinal disorders. On the one 
hand, the pharmacological study of PT-Mm 
on isolated rabbit duodenum revealed 
significant and dose-dependent increase in 
tonicity and amplitude of the spontaneous 
contractions for varying concentrations (40 
and 200 µg/mL). Similar results were 
demonstrated with Harpagophytum 
procumbens on smooth muscle preparations 
(Mahomed et al., 2005). Furthermore, it is 
well documented that acetylcholine (ACh) 
produces spasmogenic effect (Nene-Bi et al., 
2009) as PT-Mm on the same muscle. ACh is 
known to induce contraction by the activation 
of muscarinic receptors (Naseri and Heidari, 
2007) which in turn, increases the intracellular 
calcium though inositol triphosphate (IP3) 
(Naseri and Heidari, 2007) and also by 
facilitating the inflow of extracellular calcium 
though the receptor-operated calcium channel 
(Zang et al., 2005). The fact that PT-Mm 
presented myostimulant action as Ach, 
allowed us to suggest that the plant extract 
may be contained cholinergic active 
constituents which would explain its use in the 
treatment of intestinal diseases.   
On the other hand, our results have 
indicated that, the different concentrations of 
atropine (an inhibitor of the muscarinic 
receptors) reduced significantly (P 0.05) the 
increasing effect of the extract by the decrease 
of the amplitudes of contraction. Atropine 
blocked the activation of muscarinic receptors 
which caused the muscle contraction. This 
antagonistic test shows the existence of 
cholinomimetic compounds and precisely 
muscarinic receptors which are responsible for 
myostimulant effects in PT-Mm extract. 
These observations are in concordance with 
the findings of Goueh et al. (2009) and Meite 
et al. (2010) on the extracts of and Trema 
guineensis and Mareya micrantha 
respectively. 
This study had also shown that 
nifedipine completely inhibited (p 0.01) the 
effect of extract by its calcium channels 
blocking action.  We can say that, when 
nifedipine blocks calcium channels, the effect 
of plant extract is inhibited because the 
smooth muscle contraction (including rabbit 
duodenum), essentially depends an increase in 
the cytoplasmic free calcium, which activates 
the contractile elements. Furthermore the 
increase in intracellular calcium is due to 
either influx via voltage-dependent calcium 
channels or to release from intracellular stores 
in the sarcoplasmic reticulum (Bashir et al., 
2011). Thus, PT-Mm induced its effect though 
opening calcium channels. This result is 
similar with the works of Gilani et al. (2007) 
on Saussured lappa. 
In addition to its cholinergic effect, this 
study demonstrates the inhibition of AChE by 
PT-Mm. This anticholinesterase activity of 
PT-Mm corresponds to duodenal contraction. 
It should be noted that AChE has several 
peripheral anomeric catalytic sites (Johnson 
and Moore, 2006).These peripheral sites 
include the accelerating sites which would be 
the sites of binding of activators and inhibiting 
sites which would bind the inhibiting 
compounds. PT-Mm exerted a non-
competitive inhibiting effect on AChE. These 
cholinomimetic and anticholinesterase effects 
are comparable with those of prostigmine and 
neostigmine which, by inhibiting AChE, 
increase the peristaltic movement of the 
intestinal smooth muscle (Krakowsky et al., 
1997). This observation agrees with earlier 
reports (Mahomed et al., 2005; Dodehe et al., 
2010) on some biological activities of 
Harpagophytum procumbens and Combretum 
molle respectively.  
 
Conclusion 
The results of this work revealed that 
PT-Mm contains pharmacologically active 
molecules which exert cholinomimetic and 
anticholinesterasic effects on duodenal 
smooth muscle. This physiological activity 
could support the use PT-Mm extract of 
Morinda morindoïdes in the treatment of 
intestinal disorder. Further research needed to 




fractionate PT-Mm extract and isolate the 
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